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In 1994 the U.S. Occupational Health and Safety Administration (OSHA) published a study of risk
assessment for heart disease and lung cancer resulting from workplace exposure to environmental
tobacco smoke (ETS) among nonsmokers. This assessment is currently being revised. The present
article considers different possible approaches to a risk assessment for heart disease among
nonsmokers resulting from workplace ETS exposure, reviews the approach taken by OSHA in 1994,
and suggests some modifications to that approach. Since 1994 the literature supporting an
association between ETS exposure and heart disease among never smokers (sometimes including
long-term former smokers) has been strengthened by new studies, including some studies that
have specifically considered workplace exposure. A number of these studies are appropriate for
inclusion in a meta-analysis, whereas a few may not be due to methodological problems or
problems in exposure definition. A meta-analysis of eight relative risks (either rate ratios or odds
ratios) for heart disease resulting from workplace ETS exposure, based on one reasonable selection
of appropriate studies, yields a combined relative risk of 1.21 (95% confidence interval [Cl],
1 .04-1 .41). This relative risk, which is similar to that used by OSHA in 1994, yields an excess risk of
death from heart disease by age 70 of 7 per 1000 (95% Cl 0.001-0.013) resulting from ETS
exposure in the workplace. This excess risk exceeds OSHA's usual threshold for regulation of 1 per
1000. Approximately 1,710 excess ischemic heart disease deaths per year would be expected
among nonsmoking U.S. workers 35-69 years of age exposed to workplace ETS. Key words:
environmental tobacco smoke, heart disease, risk assessment. - Environ Health Perspect
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Environmental tobacco smoke (ETS) has
been shown consistently to cause heart disease
among never smokers in a large number of
studies, and the association can be reasonably
assumed to be causal, especially for a public
health agency charged with protecting
employees from involuntary risks. In 1994
the U.S. Occupational Safety and Health
Administration (OSHA) published a prelimi-
nary risk assessment for ETS, attempting to
quantify the excess risk from lung cancer and
heart disease attributable to ETS. Here I
review different possible approaches to risk
assessment for ETS, consider the most recent
literature, suggest some changes to the origi-
nal OSHA approach in the light of more
recent literature, and calculate one reasonable
estimate of excess risk for heart disease among
nonsmokers exposed to ETS
Two General Approaches to
ETS Risk Assessment
As there are many ways to do risk assessment,
the subject can be divided between two gen-
eral approaches: a) a unit risk or continuous
approach, and b) exposed/nonexposed or cat-
egorical approaches. In approach a, one deter-
mines excess lifetime risk by level of exposure,
usually in terms of a unit risk, i.e., the life-
time excess risk per unit of exposure. For this
approach exposure must be measured quan-
titatively (e.g., pIg/m3 of air nicotine for
ETS). This approach relies on quantitative
dose-response analyses of animal or epidemi-
ologic data (usually via modeling) from a sin-
gle study or a variety of studies.
In approach b, one determines the excess
lifetime risk due to exposure compared with
nonexposure; this determination is usually
based on epidemiologic studies that consider
relative risks for exposed compared to non-
exposed populations (relative risk is hereafter
taken generically to mean either rate ratios or
odds ratios). Again, one can rely on a single
study or a meta-analysis of numerous studies in
determining the relative risk. Modeling expo-
sure-response relationships is not required.
Both types of risk assessment must
ultimately convert a relative risk for a popula-
tion to an individual lifetime excess risk as of
a certain age. OSHA generally seeks to limit
exposure to a level (over a 45-year working
lifetime) that entails an excess risk of death or
serious disease less than 1 in a 1000.
Applicability of the Two
Approaches to ETS
Epidemiology
In the case of ETS and heart disease, no
epidemiology study provides quantitative
dose-response analyses by some measurable
exposure such as nicotine in the air. Tunstall-
Pedoe et al. (1) relate urinary cotinine to heart
disease in Scotland, but the cross-sectional
design makes causal inference difficult [the
situation is not much better for lung cancer;
there is only a single study with small num-
bers, which uses baseline levels of urinary coti-
nine to measure exposure (2)]. To use
approach a, one must convert the qualitative
ETS measures used in epidemiology (exposed
as work, smelled smoke at work, occasional
exposure at work, regular exposure at work) to
estimated quantitative levels of an agent, with
air nicotine as the most likely candidate.
One method for this approach is to use
some existing industrial hygiene measurements
of workplace exposures to crudely estimate the
average exposure for someone reporting expo-
sure to ETS at work. Most epidemiologic
studies date from the era prior to the establish-
ment of workplace policies restricting smok-
ing, so the data from workplaces without
smoking restrictions would be most relevant.
Hammond et al. (3) measured air nicotine in
area samples in worksites without smoking
restrictions and found a median of 8 pg/m3 in
1992. Similar exposure levels to air nicotine
were found in some areas of hospitals in 1987
(4) and more recently among casino workers
using personal sample (5). Exposure levels may
have been somewhat higher in workplaces in
the 1980s when subjects in epidemiologic
studies were exposed, as the prevalence of
smoking was higher in the 1980s. Hammond
(6) has provided the most thorough summary
to date ofworkplace ETS exposure.
One could then try to apply these exposure
data more or less directly to the relevant epi-
demiologic studies, simply assuming measured
levels in a variety of workplaces could be aver-
aged and applied to subjects in the epidemio-
logic studies. In one case there are some
measured workplace exposures (4) for a spe-
cific occupational group that has been studied
epidemiologically [nurses in Boston (7)],
although not for the specific subjects studied.
A second method for applying approach a
is to use assumptions about the average work-
place setting to derive estimated workplace
concentrations of nicotine; to use this
method, one must make assumptions about
This articles is based on a presentation at the
Workshop on Environmental Tobacco Smoke Risk
Assessment held 9-10 July 1998 in Baltimore,
Maryland.
Address correspondence to K. Steenland, MS R13,
NIOSH, 4676 Columbia Parkway, Cincinnati, OH
45226. Telephone: (513) 841-4431. Fax: (513) 841-
4486. E-mail: knsl@cdc.gov
Received 1 June 1999; accepted 23 September
1999.
Environmental Health Perspectives * Vol 107, Supplement 6 * December 1999 859
K. STEENLAND
the amount smoked in the presence of the
index subject, the number of smokers in the
room, the duration of the smoking exposure,
the size of the room where the smoking took
place, and the ventilation rate in the room,
etc. Hammond (6) and Repace and Lowrey
(8) developed models to make such estima-
tions. Because of the lack of data on the para-
meters required, this method seems less
attractive than simply applying an average of
measured workplace exposures.
Because of the limitations to the
dose-response approach (approach a) out-
lined above, the more feasible approach to
risk assessment may be b, based on rate ratios
(or relative risks) comparing exposed to non-
exposed. In this approach, one would obtain
the best estimate of the rate ratio or relative
risk of heart disease resulting from workplace
ETS exposure compared to no such exposure.
This might involve picking one large well-
designed and representative study to obtain
the relative risk, or conducting a meta-analy-
sis of epidemiologic studies (see next section).
This estimated relative risk would then be
used along with a known background rate of
heart disease among never smokers (or possi-
bly never smokers and long-term ex-smokers)
to determine a lifetime excess risk of death.
This approach was adopted by OSHA in its
1994 risk assessment (9).
OSHA's 1994 Risk Assessment
In 1994 OSHA issued a risk assessment for
ETS and two end points-lung cancer and
heart disease (9). OSHA's original methodol-
ogy for heart disease was to rely on a single
relative risk based on the Helsing et al. cohort
study (10) of never smokers exposed to ETS
at baseline in 1963 and followed for 12 years.
Exposure was determined by living with a
smoker or ex-smoker. The relative risks were
1.31 for men and 1.24 for women, adjusted
for several confounders. These relative risks
due to exposure at home were assumed to
apply to the workplace, under the reasonable
assumption that exposures in different set-
tings are likely to have similar effects, and
under the assumption that exposure levels in
the workplace were comparable in intensity
to exposure levels at home (3).
At this point OSHA could have proceeded
to estimate excess lifetime risk for an exposed
individual on the basis of a known background
rate of heart disease (or mortality) among non-
smokers, as well as standard formulas for con-
verting rates to risk. However, OSHA chose to
use an alternative but similar procedure, i.e., to
estimate the number of heart disease deaths
attributable annually to ETS exposure, then
divide this estimate by the population at risk.
OSHA estimated the percentage of non-
smokers at 73%, based on a 1991 Health
Interview Survey (HIS) (9). OSHA then
determined the percentage of nonsmoking
workers exposed to ETS in the workplace,
which was taken either as 18.8% from HIS
data or as 49% from a survey of 339 subjects
by Cummings et al. (11). Both these num-
bers were used to calculate two different esti-
mates of annual deaths attributable to ETS.
Background levels of expected heart
disease among never smokers were taken from
the study in Framingham, Massachusetts, and
averaged for men and women as 3 per 1000
during age 35-64. Using the relative risks for
ETS exposure from Helsing et al. (10) and
conventional formulas for attributable risk,
OSHA determined the number of excess
heart disease deaths expected annually due to
workplace ETS exposure. This differed
depending on whether the prevalence of
exposure among nonsmoking workers was
judged to be 19 or 49%.
OSHA then divided the number of
annual excess deaths resulting from ETS
exposure by the population at risk to derive
an annual risk, then converted this annual
risk to a lifetime risk, assuming continuous
exposure over a 45-year working lifetime
through age 65. The excess lifetime risk was 7
or 16 per 1000, depending again on which
estimated number of excess deaths was used
to derive the annual and lifetime risk. Both
estimated excess risks exceeded the excess risk
level (1 per 1000) that OSHA usually consid-
ers acceptable and justified OSHA's call for
eliminating smoking from the workplace.
Issues for a Revised Risk
Assessment of ETS and
Heart Disease
Causality, Mehanisms, and
Epidemiology ofETS Exposure
at Home
The case for a causal relation between ETS
and heart disease has been strengthened since
the publication of OSHA's 1994 risk assess-
ment (9). There are now 19 studies of heart
disease among never smokers exposed to ETS
from spousal smoking. Law et al. (12) have
reviewed these studies and found them rela-
tively homogeneous, with a common relative
risk estimated to be 1.30 (1.22-1.38) in a
meta-analysis. This excess risk is at the lower
limit ofwhat can be reasonably detected with
some certainty by epidemiologists and the
possibility that it could be due to confound-
ing needs to be considered. However, there
exist reasonable data indicating that the
observed excess risk is unlikely to result from
confounding by traditional cardiovascular
risk factors. Most studies controlled for many
cardiovascular risk factors; furthermore, in
many studies (some with relatively homoge-
neous populations) control over cardiovascu-
lar risk factors often had no or little effect on
the relative risks, indicating confounding was
not important.
The size of this relative risk (1.30) seems
high when compared to that of mainstream
smoking of 20 cigarettes a day [relative risk of
1.78, as estimated by Law et al. (12)] if one
assumes that ETS exposure corresponds to
smoking only a small amount, on the order of
1 cigarette a day. There are two counter argu-
ments to this point. First, mainstream smoke
and ETS are qualitatively different, and it is
not clear how to derive a "cigarette equivalent"
for ETS exposure. Usually the calculation of
cigarette equivalency has been based on coti-
nine in the urine of mainstream smokers and
nonsmokers exposed to ETS. However, it is
not known which components of mainstream
tobacco smoke cause increased heart disease,
and hence it is not known which component
would best be compared between sidestream
and mainstream smoke to derive a cigarette
equivalent (for example, carbon monoxide, rel-
atively more prevalent in sidestream smoke,
might be a better marker than urinary coti-
nine). However, even if one accepts that ETS
exposure is approximately equivalent to 1 ciga-
rette per day, the predicted cardiovascular
effects may be not much different from what
has been observed. Law et al. (12) argue that
the epidemiology for mainstream smoke sug-
gests that smoking one cigarette a day would
yield a relative risk on the order of 1.30.
Furthermore, there are experimental data,
principally on platelet aggregation, that also
suggest that smoking only one cigarette a day
would result in an excess risk as high as 30%.
These issues have been discussed previously in
the literature (13), and one can condude that
there are reasonable arguments, based on both
experimental and ancillary epidemiologic evi-
dence, for the biologic plausibility of an excess
risk of30% for ETS exposure.
It appears from most of the data that the
principal risk of heart disease is is from an
acute effect, e.g., on platelet aggregation.
However, there is also some evidence of
chronic effects, e.g., an increase in endothelial
thickness of the carotid artery with ETS
exposure (14). Some of the epidemiologists
who have considered the question suggest
that only those exposed to current smokers at
baseline (in cohort studies) show an excess
risk but not those exposed in the past to for-
mer smokers, an observation consistent with
an acute effect.
Relative Risk forWorkplace Exposure
At the time of the original 1994 OSHA risk
assessment, there were very few studies report-
ing the relative risk for never smokers exposed
to ETS in the workplace, which forced OSHA
to rely on a study of heart disease among non-
smokers exposed at home. Since that time
there are a number of new studies reporting
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relative risks for the workplace. The eight
studies reporting relative risk for ETS in the
workplace have recently been reviewed by
Wells (15), who reports a relative risk of 1.50
for the three best studies, and of 1.18 when all
eight studies are considered. The range of 13
relative risks (men and women are reported
separately in studies in which both were stud-
ied) in these studies goes from 0.66 to 1.85.
The highest and lowest relative risks are some-
what outliers with wide confidence intervals;
excluding the results in a range of relative risks
from 0.95 to 1.68.
It is preferable to consider studies of ETS
exposure in the workplace because the excess
risk that one seeks to measure is that which
results from workplace exposure. However, it
is worth noting that it is much more difficult
to measure workplace ETS exposure than
home exposure by a single question on a
questionnaire. While "do you live with a
smoker" is reasonably precise, "are you
exposed at work" is quite imprecise, with
exposure possibly varying from 5 min a day at
a distance of 100 ft from a smoker, to 8 hr a
day at a distance of 5 ft. This imprecision is
likely to lead to random misclassification of
workplace exposure that will usually cause a
bias to the null for workplace relative risks.
One issue in considering ETS workplace
exposure is what to do about ETS home expo-
sure. Some studies have reported a relative risk
for ETS workplace exposure after adjusting or
stratifying on home ETS exposure but most
have not. Kawachi et al. (7) estimated the rel-
ative risk for those exposed at the workplace
only compared to those with no exposure at
home or work. This is a relevant odds ratio for
OSHA's purposes, although the universe at
risk from workplace ETS also includes work-
ers exposed both at home and work.
Therefore, one might wish to estimate the rel-
ative risk due to workplace exposure (vs no
workplace exposure), as a weighted average
across those exposed at home or those not
exposed at home (e.g., stratifying on or adjust-
ing for home ETS exposure). Absent such
adjustment over home exposure, one would
hope that home ETS exposure is approxi-
mately the same for the workplace exposed
and the workplace nonexposed. A priori this
might be unlikely given that home and work
exposures may be correlated. However, some
empirical data suggest that home and work
exposures might not be strongly correlated. In
a large representative sample of the U.S. pop-
ulation [Third National Health and Nutrition
Examination Survey (NHANES III) (16)],
80% of nonsmokers reporting workplace
exposure reported no home exposure. In my
own analyses below, given the lack of data in
most studies, I have used relative risks for
workplace exposure without considering
home exposure.
Another issue is that it is probably
preferable to include only the employed in
these analyses of workplace exposures, as the
exposed-at-work are by definition employed,
whereas the nonexposed may not be
employed. Employment or the "healthy
worker effect" may act as a confounder here.
Those not actively employed tend to have
higher background heart disease rates, poten-
tially biasing relative risks downward. In addi-
tion, the population of interest to OSHA is the
employed. However, most studies have not
restricted the nonexposed to the employed.
It would not appear appropriate to
conduct a simple meta-analysis of the eight
studies ofETS workplace exposure to estimate
a common relative risk, regardless of whether
formal tests of heterogeneity indicate that they
might be combined. Some qualitative consid-
eration of which studies to include would
appear necessary, and several different selec-
tion criteria and meta-analyses might be con-
ducted using a sensitivity analysis. In some
studies the methods are either sketchy or sug-
gest problems and/or the exposure definition
is absent or imprecise (17,18). One study is
restricted to a high-risk population and the
definition of exposure is indirect ("Did most
of your co-workers smoke?") (19). One study
was conducted in China where exposure con-
ditions may be somewhat different (possibly
higher prevalence and intensity of workplace
exposure), but the study is well designed and
would seem to be a candidate for inclusion, as
the effects ofETS on the heart should be simi-
lar in different countries (20). Two studies are
unpublished PhD dissertations (18,21), but
this should not exclude them if they are valid
and well-conducted studies.
Excluding three studies for the reasons
stated above (17-19), one reasonable set of
studies to include would be the four studies
from the U.S. and one from China without
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any apparent major design or exposure defi-
nition problems (7,20-23). Three are
cohort studies (7,21,23), whereas two are
case-control (20,22); three are based on
incidence (7,20,22), whereas two are based
on mortality (21,23). The workplace expo-
sures occurred generally in the early 1980s,
although the time frame for exposure in the
study of Muscat and Wynder (22) is not
given. Some of these studies include morbid-
ity and mortality data as well as different defi-
nitions of heart disease, but these issues can
probably be reasonably ignored. These five
studies show eight relative risks (some include
men and women separately) ranging from 1.0
to 1.85 (Figure 1). Two studies (7,20) pro-
vide dose-response data. Both these studies
suggest a positive trend, which tends to
strengthen the case for a true workplace
effect. Although it appears in these eight
studies that women have higher relative risks
than men, the differences between the male
and female relative risks are not statistically
significant. More important, the more abun-
dant data from studies of spousal ETS indi-
cate that the relative risks for men and
women are very similar, and the apparent dif-
ferences between men and women in work-
place ETS exposure studies could well be
attributed to statistical variation. Therefore
we consider here all eight studies together,
without stratifying on gender. The combined
relative risk from these eight studies weight-
ing each study's log relative risk by the inverse
of its variance (24) and using a fixed effects
model (the heterogeneity test is not signifi-
cant) is 1.21 (95% confidence interval [CI],
1.04-1.41). This relative risk is insensitive to
the inclusion or exclusion of specific studies,
so that most reasonable selections of studies
to include will yield a similar result. For
example, exclusion of the study with the
highest relative risk [the Chinese study (20)]
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Figure 1. Studies of heart disease and workplace ETS.
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yields a combined relative risk of 1.19 (95%
CI, 1.02-1.39).
The above relative risk (1.21) is probably
a conservative estimate, underestimating the
true relative risk. As mentioned earlier, the
exposed group is restricted to workers
whereas the referent is not, so that the
healthy worker effect may cause a bias
towards the null.
Conversion of Relative Risk to Lifetime
Individual Risk
It seems reasonable that lifetime excess risk
should be calculated through age 69, as most
workers retire around that age and the heart
disease risk from ETS exposure might be
expected to wear off within a short time of
ceasing exposure (assuming a primarily acute
effect). To calculate lifetime excess risk, one
uses conventional formulas for converting
rates to risks. For a common cause such as
heart disease, it is preferable to consider com-
peting causes of death in calculating lifetime
risks, via an adjustment proposed by Gail
(25). Gail's formula is as follows:
69
E.tcess risk = (rr - 1) * ql(i)
i=35
exp[- (rr - 1)q, (j)+q, (j)]
J=35
where excess risk refers to cumulative excess
risk of ischemic heart disease death by age 69,
rr is the rate ratio for ischemic heart disease
for ETS-exposed nonsmokers versus non-
smokers not exposed to ETS, ql is the
ischemic heart disease mortality rate for non-
smokers, qa is the overall all-causes mortality
rate for nonsmokers. Here we assume no
increased rates of heart disease for nonsmok-
ers until after age 35, based on a background
rate close to 0 at these early ages.
Using the results of the meta-analysis
above (rate ratio = 1.21), the lifetime excess
risk of heart disease death due to ETS work-
place exposure among never smokers is 0.004
(95% CI, 0.001-0.008) by age 65, increasing
to 0.007 (95% CI, 0.001-0.013) by age 70.
An assumption of an ETS risk persisting until
age 70 is reasonable either because people
continue to work and be exposed or because
the risk is assumed to persist 5 years after
exposure. This excess risk exceeds the level of
risk usually acceptable to OSHA (0.001). In
this calculation I have assumed an ischemic
heart disease death rate for never smokers of
6/100,000 (men and women combined)
between age 35-44, a rate 89/100,000 from
age 45-64, and a rate of 307/100,000 for age
65-69, as estimated from four large cohorts
of never smokers (26). No heart disease
death risk was assumed prior to age 35, and
U.S. age-specific mortality rates from 1996
were used for the correction for competing
causes of death.
Attributable Risk
An estimation of attributable risk is not
required for calculating excess lifetime risk
but can be a useful exercise from the point
of view of public health. Some modifica-
tions might be made to OSHA's previous
methods. The population at risk should
probably be employed men and women
who are never-smokers or former smokers
who have quit at least 5 years earlier, rather
than all nonsmokers. Estimates of these
numbers are available from the 1991 HIS
survey. Former smokers who quit more than
5 years ago have a similar background risk
as never-smokers.
The number of ETS-exposed among the
population at risk is a more difficult question.
It would seem best to estimate this number of
large national representative surveys. The HIS
survey in 1991 estimated 18% of nonsmokers
were exposed to ETS at work. The NHANES
III survey (16) estimated in 1988-1991 that
25% of nonsmokers were exposed at work
(could smell tobacco smoke). These percent-
ages would have to be adjusted downward to
exclude recent former smokers. Furthermore,
as workplace smoking policies are more com-
mon, the most recent data should be used
and would also presumably show somewhat
lower percent ages.
Gerlach et al. (27) found in a 1991-1992
survey of 100,000 workers in indoor environ-
ments, excluding the self-employed, that 33%
of nonsmokers reported working in work-
places without smoking restrictions. These
numbers would seem to correspond roughly
to the percentages of nonsmokers reporting
exposure in HIS and NHANES III. It is
likely the numbers have decreased since the
early 1990s because of increased numbers of
worksites with smoking restrictions.
For the purposes of my estimates here, I
will assume that roughly 20% of nonsmok-
ers are exposed to ETS as work. I will also
assume (following OSHA's 1994 calcula-
tions) that there are approximately
74,000,000 nonsmokers, age 18 to 65, in
U.S. workplaces. From demographic data I
estimate that approximately 52,000,000
(70%) of these workers are age 35-65 (28)
and that there are an additional 5 million
ex-workers age 65-69 still at risk from the
effects of ETS, so that the population of
nonsmokers at risk totals approximately
57,000,000. Using a weighted average across
four cohort studies on nonsmokers (26) and
assuming equal numbers of men and
women, I estimate an annual ischemic heart
disease mortality rate of approximately
75/100,000 in nonsmoking workers age
35-69. Using the standard formula for
attributable fraction (AF = p(rr - 1)I{p(rr -
1) + 11, herep= 0.2, rr= 1.21), one obtains
an approximate attributable fraction of 4%.
This attributable fraction in turn leads to an
approximate estimate of 1,710 ischemic
heart disease deaths a year expected among
nonsmoking workers age 35-69 resulting
from ETS exposure (57,000,000 x
75/100,000 x 0.04). This number increases
dramatically if one assumes that ETS has a
chronic effect that extends beyond age 70,
because the background rate for heart dis-
ease shows a large increase at older ages (the
rate among nonsmokers more than 70 years
of age is approximately 1200/100,000, an
additional approximately 24 million ex-
workers would be at risk, and approximately
11,500 excess deaths from ETS exposure
would be expected in this group).
These estimated numbers of excess deaths
would also change if the proportion exposed
were lower or higher. For example, if in the
future fewer people smoke and the propor-
tion exposed to ETS at work decreases to
10%, the attributable fraction would decrease
to 2%, and the number of excess deaths
among nonsmokers age 35-69 drops by half,
to 855 deaths. If, on the other hand, smoking
were to increase, and the proportion exposed
increased to 30%, the attributable fraction
would increase to 6%, and we would expect
2565 excess deaths by age 69.
Conclusion
ETS has been shown consistently to cause heart
disease among never smokers in a large number
of studies; the association can be reasonably
assumed to be causal, especially for a public
health agency charged with protecting employ-
ees from involuntary risks. The approach to cal-
culating excess lifetime risk suggested here
follows OSHA's earlier risk assessment, but
with some modifications. These modifications
include using newer epidemiologic studies with
relative risks specific to workplace ETS expo-
sure. There are a number of uncertainties
involved in this risk assessment; perhaps
the most important is knowledge of the true
relative risk for workplace ETS exposure.
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